Open Access
CC BY 4.0 · Endoscopy 2026; 58(S 01): E158-E159
DOI: 10.1055/a-2776-7961
E-Videos

A novel endoscopic ultrasound system assisted by artificial intelligence for the recognition of pancreatic parenchyma and the detection of solid/cystic lesions

Authors

  • Sho Takahashi

    1   Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan (Ringgold ID: RIN73362)
  • Tomoya Takahashi

    1   Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan (Ringgold ID: RIN73362)
  • Toshio Fujisawa

    1   Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan (Ringgold ID: RIN73362)
  • Ippei Ikoma

    1   Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan (Ringgold ID: RIN73362)
  • Yasuhisa Jimbo

    1   Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan (Ringgold ID: RIN73362)
  • Ko Tomishima

    1   Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan (Ringgold ID: RIN73362)
  • Hiroyuki Isayama

    1   Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan (Ringgold ID: RIN73362)
 

Endoscopic ultrasound (EUS) is an essential modality for detecting pancreatic solid and cystic lesions. However, EUS skill acquisition remains difficult for trainee endoscopists [1]. To facilitate the skill acquisition of trainee endoscopists, an EUS system assisted by artificial intelligence (EUS-AI), EW10-US01 (CAD EYE; FUJIFILM Corporation, Tokyo, Japan), has recently been developed and released for clinical use [2] [3]. This system provides two functions: recognition of the pancreatic parenchyma, visualized as a white cross, and detection of solid and cystic lesions, visualized as a blue box. These outputs are overlaid in real time on live EUS images with optional acoustic alerts. We report a case in which this novel system contributed to the detection of pancreatic solid lesions that had not been identified via magnetic resonance imaging (MRI).

An 81-year-old woman presented with worsening control of type 2 diabetes mellitus, which prompted further MRI evaluation. The examination revealed a 15 mm hyperintense lesion in the pancreatic tail in diffusion-weighted imaging ([Fig. 1] a, b). In addition, a 13 mm cystic lesion in the pancreatic body was identified in heavy T2 weighted images ([Fig. 1] c, d). For diagnostic confirmation, EUS-guided tissue acquisition (EUS-TA) was performed with the assistance of EUS-AI ([Video 1]). After the previously identified lesion in the pancreatic tail had been confirmed ([Fig. 2]), subsequent screening with EUS-AI identified another a solid 12 mm lesion adjacent to the cyst in the pancreatic body, which had not been detected via MRI ([Fig. 3]). EUS-TA of both lesions was performed, and pathological examination confirmed adenocarcinoma. This patient underwent pancreaticoduodenectomy.

Zoom
Fig. 1 a Diffusion-weighted imaging (DWI) demonstrated a 15 mm hyperintense lesion in the pancreatic tail (red arrow). b Heavily T2-weighted imaging did not demonstrate a corresponding lesion. c DWI did not demonstrate a solid lesion with diffusion restriction in the pancreatic body. d Heavily T2-weighted imaging demonstrated a 13 mm cystic lesion in the pancreatic body (yellow arrow).
Zoom
Fig. 2 Using the EUS-AI system, the 15 mm lesion in the pancreatic tail previously detected via MRI was enclosed by the blue box. EUS-AI, EUS system assisted by artificial intelligence; MRI, magnetic resonance imaging.
Zoom
Fig. 3 EUS-AI detected the 12 mm lesion in the pancreatic body adjacent to the cyst that had not been detected via MRI. EUS-AI, endoscopic ultrasound system assisted by artificial intelligence; MRI, magnetic resonance imaging.
Real-time recognition of the pancreatic parenchyma and detection of solid/cystic lesions by an artificial intelligence-assisted EUS system. EUS, endoscopic ultrasound.Video 1

This case highlights the clinical feasibility of this commercially available EUS-AI system that provides the real-time recognition of pancreatic parenchyma and detection of solid and cystic lesions in routine practice. EUS-AI may contribute to more accurate examinations by facilitating the skill acquisition of trainee endoscopists.

Endoscopy_UCTN_Code_CCL_1AF_2AZ


Contributorsʼ Statement

Sho Takahashi: Data curation, Writing – original draft. Tomoya Takahashi: Writing – review & editing. Toshio Fujisawa: Writing – review & editing. Ippei Ikoma: Writing – review & editing. Yasuhisa Jimbo: Writing – review & editing. Ko Tomishima: Writing – review & editing. Hiroyuki Isayama: Conceptualization, Writing – review & editing.

Conflict of Interest

Author H. I. was supported by research grants from FUJIFILM Corporation. The funding source has no role in the design, practice, or analysis of this study. The remaining authors have no conflicts of interest to disclose.


Correspondence

Hiroyuki Isayama, MD, PhD
Department of Gastroenterology, Graduate School of Medicine, Juntendo University
2-1-1 Hongo, Bunkyo-Ku
Tokyo, 113-8421
Japan   

Publication History

Article published online:
30 January 2026

© 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany


Zoom
Fig. 1 a Diffusion-weighted imaging (DWI) demonstrated a 15 mm hyperintense lesion in the pancreatic tail (red arrow). b Heavily T2-weighted imaging did not demonstrate a corresponding lesion. c DWI did not demonstrate a solid lesion with diffusion restriction in the pancreatic body. d Heavily T2-weighted imaging demonstrated a 13 mm cystic lesion in the pancreatic body (yellow arrow).
Zoom
Fig. 2 Using the EUS-AI system, the 15 mm lesion in the pancreatic tail previously detected via MRI was enclosed by the blue box. EUS-AI, EUS system assisted by artificial intelligence; MRI, magnetic resonance imaging.
Zoom
Fig. 3 EUS-AI detected the 12 mm lesion in the pancreatic body adjacent to the cyst that had not been detected via MRI. EUS-AI, endoscopic ultrasound system assisted by artificial intelligence; MRI, magnetic resonance imaging.